Tod Smeal
Chief Tech/Sci/R&D Officer at CARDIFF ONCOLOGY, INC.
Net worth: - $ as of 2024-03-30
Profile
Tod Smeal is currently the Chief Scientific Officer at Cardiff Oncology, Inc. He previously held positions as the Director-Oncology Research Unit at Pfizer Inc. from 2003 to 2015, the Chief Scientific Officer at Eli Lilly & Co. from 2015 to 2020, and the Chief Scientific Officer at Hexagon Bio, Inc. from 2020 to 2021.
Dr. Smeal obtained his undergraduate degree from the Massachusetts Institute of Technology and his doctorate degree from the University of California San Diego.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
CARDIFF ONCOLOGY, INC.
-.--% | 2024-03-06 | 0 ( -.--% ) | - $ | 2024-03-30 |
Tod Smeal active positions
| Companies | Position | Start |
|---|---|---|
| CARDIFF ONCOLOGY, INC. | Chief Tech/Sci/R&D Officer | 2022-01-10 |
Former positions of Tod Smeal
| Companies | Position | End |
|---|---|---|
Hexagon Bio, Inc.
 Hexagon Bio, Inc. BiotechnologyHealth Technology Hexagon Bio, Inc. operates as a data-driven biotechnology company. It engages in mining of fungal genome data for drugs. The company was founded by Maureen E. Hillenmeyer, Brian T. Naughton, Colin James Bell Harvey and Yi Tang and is headquartered in Menlo Park, CA. | Chief Tech/Sci/R&D Officer | 2020-12-31 |
| ELI LILLY AND COMPANY | Chief Tech/Sci/R&D Officer | 2019-12-31 |
| PFIZER, INC. | Corporate Officer/Principal | 2014-12-31 |
Training of Tod Smeal
| Massachusetts Institute of Technology | Undergraduate Degree |
| University of California San Diego | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| PFIZER, INC. | Health Technology |
| CARDIFF ONCOLOGY, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Hexagon Bio, Inc.
Hexagon Bio, Inc. BiotechnologyHealth Technology Hexagon Bio, Inc. operates as a data-driven biotechnology company. It engages in mining of fungal genome data for drugs. The company was founded by Maureen E. Hillenmeyer, Brian T. Naughton, Colin James Bell Harvey and Yi Tang and is headquartered in Menlo Park, CA. | Health Technology |
- Stock Market
- Insiders
- Tod Smeal
